Rik van Heijningen has been named vice president of commercial operations for genomics and proteomics at Kreatech, the Dutch biotechnology company said last week.
According to Kreatech, van Heijningen will focus on corporate and business development for the firm’s protein, gene expression, and array comparative genomic hybridization reagent kits.
Prior to joining Kreatech, van Heijningen held several sales and marketing positions with Dynal Biotech and Invitrogen in Norway, Germany, and The Netherlands.